A unicorn stalks Wall Street in search of IPO cash; CASI Pharma in-licenses CD19 therapy from China’s Juventas
→ A herd of upstart biotechs will look to Wall Street for some major windfalls this week as a burst of new offerings …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
